Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis

Intern Med. 2020 Feb 1;59(3):429-433. doi: 10.2169/internalmedicine.3216-19. Epub 2019 Oct 17.

Abstract

A 70-year-old woman with rheumatoid arthritis undergoing methotrexate (MTX) treatment presented with dyspnea and a subfever. Computed tomography (CT) revealed a diffuse minimal ground-glass appearance in both lungs and splenomegaly. The gallium scintigram showed a diffuse, mild uptake in both lungs and the spleen. The lung biopsy specimen revealed the presence of CD20-positive atypical lymphocytes in the small pulmonary vessels. The patient was diagnosed with pulmonary intravascular diffuse large B-cell lymphoma (IVLBCL) and exhibited spontaneous regression after MTX was discontinued. This report describes a rare case of MTX-associated lymphoproliferative disorder expressing pulmonary IVLBCL.

Keywords: diffuse large B-cell lymphoma; hypoxia; intravascular lymphoma; methotrexate; rheumatoid arthritis.

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / physiopathology
  • Lymphoma, Large B-Cell, Diffuse / chemically induced*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / physiopathology
  • Methotrexate / adverse effects*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Antirheumatic Agents
  • Methotrexate